Axoltis Pharma is a biopharmaceutical company dedicated to develop first-in-class disease-modifying drugs to treat patients with degenerative or traumatic neurological disorders with high unmet medical needs.
Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders.
Our products are a first-in-class multi-target peptides with high potential in many CNS disorders, as demonstrated via distinctive and multifunctional mechanism of action on neural cells, encompassing:
- Neuroprotection with strong anti-oxidative properties & anti-apoptotic activities
- Regenerative & remodeling properties including neurite outgrowth to restore lost function
- Cellular plasticity mechanisms